Print this page
Forward this page

BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle Park and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development of biologics across a number of disease states. BioAgilytix offers assay development, validation, and sample analysis under non‐GLP, GLP, and GCP, as well as GMP quality control testing (i.e., product release testing, stability testing, etc.)


BioAgilytix’s team

of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to many of the top global pharmaceutical and biotech companies.

Related News



announces acquisition of Boston-Based Clinical Research Organization Cambridge Biomedical

Proven partner to innovators of all sizes across the pharmaceutical and biotechnology industries

BioAgilytix is a bioanalytical partner to many of the top global pharmaceutical and biotechnology companies. The Company also actively supports innovators across other industries that are working to progress large molecule breakthroughs, as well as smaller biotechs and emerging biopharma sponsors. Customers continue to choose BioAgilytix as their preferred bioanalytical CRO because of the Company’s deep large molecule experience, reputation for quality, unparalleled regulatory track record and their uniquely collaborative approach.

World-class team of scientists with extensive therapeutic area expertise

BioAgilytix’s scientific team’s collective experience supporting novel drug development for a range of disease areas has made the Company a preferred partner for sponsors looking to create more effective biologic therapeutics in these fields. The Company’s BPM (bioanalytical project manager) team averages 15+ years of post-school bench experience, with more than 35% comprised of PhD and Masters-level scientists that have been working with leading pharmaceutical and CROs for 10+ years. BioAgilytix’s scientists have supported the development of many key drugs currently on the market, as well as an array of promising clinical candidates, and understand the nuances in scientific, regulatory, and data requirements across disease states – as well as the challenges to anticipate in each phase.

Cobepa S.A.

Cobepa S.A.
Rue de la Chancellerie 2, box 1
1000 Brussels
+ 32 2 213 32 10
+ 32 2 513 17 02

Cobepa North America Inc.

Cobepa North America Inc.
Tower 49
12 East 49th Street
New York, NY 10017
United States
+1 (646) 679 5177

Ibel Beteiligungsberatung GmbH (Member of Cobepa Group)

Ibel Beteiligungsberatung GmbH
Theresienstrasse 1
80333 München
+32 2 213 32 10